RoyLFreemanMD

Neurophysiology

Professor, Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School

Dr. Freeman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1 Deaconess Rd
Beth Israel Deaconess Med Ctr Palmer 111
Boston, MA 02215
Phone+1 617-632-8454

Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Neurology, 1979 - 1982
Brigham and Women's HospitalInternship, Internal Medicine, 1978 - 1979
University of Cape Town Faculty of MedicineClass of 1974

PubMed

Personalized Outcomes in Neuropathic Pain: A Clinical Relevance and Assay Sensitivity Analysis from a Randomized Controlled Trial.
Karim Saab, Umang Gada, Eva Culakova, Brian Burnette, Carla Jorgensen
Pain Medicine. 2024-10-04
1 citations
Methods for pragmatic randomized clinical trials of pain therapies: IMMPACT statement.
David Hohenschurz-Schmidt, Dan Cherkin, Andrew S C Rice, Robert H Dworkin, Dennis C Turk
Pain. 2024-10-01
Pain in Multiple System Atrophy: A Community-Based Survey.
Nicole Campese, Georg Göbel, Julia Wanschitz, Andreas Schlager, Bianca Caliò
Movement Disorders. 2024-10-01

Journal Articles

State-of-the-Art Review
Roy Freeman, Mitchell G Miglis, Christopher Gibbons, Pearl Jones, ScienceDirect

Lectures

Diabetic Peripheral Neuropathy: More Effective Treatments Needed
43rd Annual Meeting, Amsterdam, The Netherlands
Diabetic Peripheral Neuropathy: More Effective Treatments Needed
European Association for the Study of Diabetes, 43rd Annual Meeting, Amsterdam, The Netherlands

CND Life Sciences Announces Publication of Study Demonstrating Clinical Utility of the Syn-One Test® as an Important Aid in the Diagnosis and Treatment of Neurodegenerative DiseasesDecember 18th, 2024
CND Life Sciences Announces Publication of Study Demonstrating Clinical Utility of the Syn-One Test® as an Important Aid in the Diagnosis and Treatment of Neurodegenerative DiseasesDecember 18th, 2024
CND Life Sciences Enters into Licensing and Collaboration Agreement to Advance Diagnostic Technology for Neurodegenerative DiseasesMarch 22nd, 2023
Join now to see all